Fellowship · San Juan, PR
Sponsored by University of Puerto Rico School of Medicine
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
Nature medicine · 2021 · 305 citations · Ivonne Jiménez-Velázquez
Intrinsic capacity and its associations with incident dependence and mortality in 10/66 Dementia Research Group studies in Latin America, India, and China: A population-based cohort study.
PLoS medicine · 2021 · 113 citations · Ivonne Jiménez-Velázquez
Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium.
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022 · 80 citations · Ivonne Jiménez-Velázquez
Multilevel barriers to using assistive technology devices among older hispanics from poor and disadvantaged communities: the relevance of a gender analysis.
Disability and rehabilitation. Assistive technology · 2024 · 13 citations · Ivonne Jiménez-Velázquez
Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS): Study design and harmonization.
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023 · 45 citations · Ivonne Jiménez-Velázquez
Loneliness Among Older Adults in Latin America, China, and India: Prevalence, Correlates and Association With Mortality.
International journal of public health · 2021 · 52 citations · Ivonne Jiménez-Velázquez
Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study.
Lancet regional health. Americas · 2022 · 34 citations · Ivonne Jiménez-Velázquez
FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease.
Acta neuropathologica · 2022 · 37 citations · Ivonne Jiménez-Velázquez